Literature DB >> 19654587

A rapid and transient peripheral inflammatory response precedes brain inflammation after experimental stroke.

Katie Z Chapman1, Verity Q Dale, Adám Dénes, Gavin Bennett, Nancy J Rothwell, Stuart M Allan, Barry W McColl.   

Abstract

Increasing evidence suggests that peripheral inflammatory responses to stroke and other brain injuries have an important role in determining neurological outcome. The mediators of this response and the temporal relationships between peripheral and central inflammatory alterations are poorly understood. In this study, we show that experimental stroke in mice induces a peripheral inflammatory response that peaks 4 h after stroke, and precedes the peak in brain inflammation 24 h after stroke. This peripheral response is dominated by the induction of the chemokine CXCL-1 and the proinflammatory cytokine interleukin-6 and could serve as an accessible target for therapy and as a source of biomarkers predictive of prognosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19654587     DOI: 10.1038/jcbfm.2009.113

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  57 in total

1.  Piperine suppresses cerebral ischemia-reperfusion-induced inflammation through the repression of COX-2, NOS-2, and NF-κB in middle cerebral artery occlusion rat model.

Authors:  Kumar Vaibhav; Pallavi Shrivastava; Hayate Javed; Andleeb Khan; Md Ejaz Ahmed; Rizwana Tabassum; Mohd Moshahid Khan; Gulrana Khuwaja; Farah Islam; M Saeed Siddiqui; Mohammed M Safhi; Fakhrul Islam
Journal:  Mol Cell Biochem       Date:  2012-06-06       Impact factor: 3.396

2.  Vitamin D deficiency exacerbates experimental stroke injury and dysregulates ischemia-induced inflammation in adult rats.

Authors:  Robyn Balden; Amutha Selvamani; Farida Sohrabji
Journal:  Endocrinology       Date:  2012-03-09       Impact factor: 4.736

Review 3.  Revisiting the timing hypothesis: biomarkers that define the therapeutic window of estrogen for stroke.

Authors:  Farida Sohrabji; Amutha Selvamani; Robyn Balden
Journal:  Horm Behav       Date:  2012-06-19       Impact factor: 3.587

Review 4.  Modifiable Cardiovascular Risk, Hematopoiesis, and Innate Immunity.

Authors:  Maximilian J Schloss; Filip K Swirski; Matthias Nahrendorf
Journal:  Circ Res       Date:  2020-04-23       Impact factor: 17.367

5.  Autoimmune responses to brain following stroke.

Authors:  Kyra Becker
Journal:  Transl Stroke Res       Date:  2012-04-05       Impact factor: 6.829

6.  Experimental stroke-induced changes in the bone marrow reveal complex regulation of leukocyte responses.

Authors:  Adam Denes; Barry W McColl; Sophie F Leow-Dyke; Katie Z Chapman; Neil E Humphreys; Richard K Grencis; Stuart M Allan; Nancy J Rothwell
Journal:  J Cereb Blood Flow Metab       Date:  2010-11-03       Impact factor: 6.200

Review 7.  Intranasal Insulin and Insulin-Like Growth Factor 1 as Neuroprotectants in Acute Ischemic Stroke.

Authors:  Vasileios-Arsenios Lioutas; Freddy Alfaro-Martinez; Francisco Bedoya; Chen-Chih Chung; Daniela A Pimentel; Vera Novak
Journal:  Transl Stroke Res       Date:  2015-06-05       Impact factor: 6.829

Review 8.  Inflammation and Stroke: An Overview.

Authors:  Josef Anrather; Costantino Iadecola
Journal:  Neurotherapeutics       Date:  2016-10       Impact factor: 7.620

Review 9.  Role of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/CXCR2 networks.

Authors:  Bridgette D Semple; Thomas Kossmann; Maria Cristina Morganti-Kossmann
Journal:  J Cereb Blood Flow Metab       Date:  2009-11-11       Impact factor: 6.200

Review 10.  Hurdles to clear before clinical translation of ischemic postconditioning against stroke.

Authors:  Heng Zhao
Journal:  Transl Stroke Res       Date:  2013-01-11       Impact factor: 6.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.